| Elevator Pitch |
Cempra Pharmaceuticals Inc. has closed a $46 million Series C round to conduct clinical trials of antibiotics aimed at difficult-to-treat infections. |
| Industry Focus |
BioPharma |
| Category |
Companies - Expansion Stage |
| Location |
6340 Quadrangle Drive, Suite 100 |
|
Building Four Quadrangle |
|
Chapel Hill, North Carolina
27517
|
|
United States |
| |
| Phone |
(919) 467-1716 |
| Email |
Please log in |
| Web |
http://www.cempra.com |
|
|
|
Amount: $46,000,000
Closed: May 14, 2009
|
|
|
|
|
|
|
Round: Series C
Amount: Unspecified
Closed: May, 2009
|
|
|
|
|
|
|
Round: Series C
Amount: Unspecified
Closed: May, 2009
|
|
|
|
|
|
|
Round: Series C
Amount: Unspecified
Closed: May, 2009
|
|
|
|
| Be the first to recommend Cempra Pharmaceuticals!
Log in |
Public information, member edits, and the DealHorizon.com team.
|
Office Location
Statistics
Search Site
Edit/Update
Followers
Please log in
Note: Once associated with a listing, Executives are automatically included as followers of that listing. Listing
creators are also automatically added as followers.
|
